Hi Crikker ...welcome aboard ..
Shockwave is running training class's and presentations at EuroPCR19 next wk Tue-Thur .
Its a big EU Cardio conference .
I'll post info as I find it , next wk .
Couple of notes .
Some ( all ? ) of SWAV's clinical trails are using paclitaxel coated balloons . These trial(s) may be on hold until the FDA decides the long term risk of these types of balloons and stents . Something they are supposed to decide on in June.
The use of their technology to enable better delivery of large catheters for TAVR ( Mike Jagger ) type operations is apparently catching on.
Below the knee applications are due to be launched on a wider scale , with smaller devices in Q4 .
This is big for some diabetics who are at risk of having toes , feet etc amputated . Using the Rotoblator ( Atherectomy ) is risky in these locations as debris from this procedure risks blocking these small arteries preventing blood flow to the lower extremities resulting in amputation.
They also seem to be exploring more use of Shockwave as a stand alone procedure .....cracking the calcium , allowing the vessel to expand so that there is 30% or less blockage ......and then leaving it ...no stents etc .
Regards accumulation . Stock has had a huge run as investors become aware of its potential to really shift how arterial calcium is dealt with.
I'm at the "buy on pull backs " phase now .
They are about 20-24 mths away from having their coronary devices approved for wide spread use in the US ( they are approved in the EU )....and that's the big prize .